RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 51.09

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-02 )

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

N/A

USD 0.09B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

N/A

USD 8.75B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

N/A

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.22B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

N/A

N/A
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.14% 81% B- 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.14% 81% B- 95% A
Trailing 12 Months  
Capital Gain -1.64% 32% F 30% F
Dividend Return 1.49% 69% C- 26% F
Total Return -0.15% 30% F 26% F
Trailing 5 Years  
Capital Gain 88.42% 68% D+ 79% B-
Dividend Return 4.80% 61% D- 11% F
Total Return 93.22% 68% D+ 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 10.95% 25% F 66% D+
Dividend Return 11.29% 25% F 62% D
Total Return 0.35% 23% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 31.31% 97% N/A 33% F
Risk Adjusted Return 36.07% 58% F 50% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.